Related references
Note: Only part of the references are listed.Modeling risk stratification in human cancer
Thierry Reme et al.
BIOINFORMATICS (2013)
The molecular diversity of Luminal A breast tumors
Giovanni Ciriello et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Targeting triple negative breast cancer: Is p53 the answer?
Natalie Turner et al.
CANCER TREATMENT REVIEWS (2013)
Characterization of novel MPS1 inhibitors with preclinical anticancer activity
M. Jemaa et al.
CELL DEATH AND DIFFERENTIATION (2013)
Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs
Bakhos A. Tannous et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma
J. Liu et al.
ONCOGENE (2013)
DNARepair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes
Libero Santarpia et al.
ONCOLOGIST (2013)
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
Virginie Maire et al.
PLOS ONE (2013)
RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data
Balazs Gyorffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
Libero Santarpia et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
S. Murray et al.
CANCER TREATMENT REVIEWS (2012)
The rebel angel: mutant p53 as the driving oncogene in breast cancer
Dawid Walerych et al.
CARCINOGENESIS (2012)
Selective killing of p53-deficient cancer cells by SP600125
Mohamed Jemaa et al.
EMBO MOLECULAR MEDICINE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Estrogen receptor prevents p53-dependent apoptosis in breast cancer
Shannon T. Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mitotic Kinases and p53 Signaling
Geun-Hyoung Ha et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2012)
The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition
Erik Fredlund et al.
BREAST CANCER RESEARCH (2012)
Jetset: selecting the optimal microarray probe set to represent a gene
Qiyuan Li et al.
BMC BIOINFORMATICS (2011)
Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
Charles Coutant et al.
CLINICAL CANCER RESEARCH (2011)
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Multifactorial Approach to Predicting Resistance to Anthracyclines
Christine Desmedt et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
Takayuki Iwamoto et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
Herve Bonnefoi et al.
LANCET ONCOLOGY (2011)
Translating p53 into the clinic
Chit Fang Cheok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
Thomas Karn et al.
PLOS ONE (2011)
High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells
Jewel Daniel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Prognostic and Therapeutic Implications of Distinct Kinase Expression Patterns in Different Subtypes of Breast Cancer
Giampaolo Bianchini et al.
CANCER RESEARCH (2010)
Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase
Riccardo Colombo et al.
CANCER RESEARCH (2010)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial
Christine Desmedt et al.
BMC MEDICAL GENOMICS (2009)
Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
TTK/hMps1 Mediates the p53-Dependent Postmitotic Checkpoint by Phosphorylating p53 at Thr18
Yi-Fu Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples
Balazs Gyorffy et al.
PLOS ONE (2009)
Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
Aniek Janssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis
Pascal Finetti et al.
CANCER RESEARCH (2008)
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen
Philippe Bertheau et al.
PLOS MEDICINE (2007)
Gene expression patterns associated with p53 status in breast cancer
Melissa A. Troester et al.
BMC CANCER (2006)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
Scott L. Carter et al.
NATURE GENETICS (2006)
MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability
Mei Leng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death
BAA Weaver et al.
CANCER CELL (2005)
TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68
JH Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Chemical genetics reveals a role for Mps1 kinase in kinetochore attachment during mitosis
MH Jones et al.
CURRENT BIOLOGY (2005)
EDC-mediated condensations of 1-chloro-5-hydrazino-9,10-anthracenedione, 1-hydrazino-9,10-anthracenedione, and the corresponding anthrapyrazoles
M Kim et al.
TETRAHEDRON LETTERS (2004)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
